Location out of bounds
Radial
Radial

Newsroom

Resources for journalists

All Press Releases
Versiti Logo

FDA Accepts New Language For “Circular of Information for the Use of Human Blood and Blood Components”

Heartland Blood Center – November 3, 2017

AABB has updated its “Circular of Information for the Use of Human Blood and Blood Components” web page following the FDA’s approval for new language to be inserted in the November 2013 Circular. The updates have been made to provide the approved statement regarding the newly licensed Zika virus (ZIKV) nucleic acid test (NAT). The updated language is intended for use with blood products that have been tested for ZIKV using an FDA-licensed test. In such cases, the FDA requires the insertion of the following language:

  • “A licensed nucleic acid test (NAT) for Zika Virus RNA has been performed and found to be nonreactive.”

This language, developed by the Circular of Information Task Force and accepted by FDA, is similar to that required for other licensed NAT tests.

The insertion of this language is not required for blood products that have been tested for ZIKV under an Investigational New Drug (IND). In such cases, language provided by the IND sponsor remains unchanged.
AABB recommends the use of an adhesive label or an ink stamp to insert the updated language into the Circular. In addition, the version date of November 2013 will not change with this language insertion.

Contact Us

Fay Spano

Director, Public Relations and Corporate Communications
Email (414) 937-6124

Other Press Releases

Health Care Heroes Blood Drive

Blood drive pays tribute to local hospital healthcare heroes

May 21, 2020

Versiti Blood Center of Wisconsin has scheduled a Healthcare Heroes Tribute Blood Drive for Thursday, May 28, at the Zoofari Conference Center at the Milwaukee County Zoo.

Read More
Versiti Logo

Versiti receives grant from Advancing Healthier Wisconsin Endowment (AHW) to advance convalescent pl

April 21, 2020

Grant of nearly $400 thousand will help to find treatment for COVID-19 patients.

Read More
Versiti Logo

Versiti creates special hotline and electronic form to enable recovered COVID-19 patients to donate

April 9, 2020

Versiti blood centers, among the first in the U.S. to begin collecting convalescent plasma, is actively seeking recovered COVID-19 patients to donate convalescent plasma.

Read More
x

This website uses cookies to ensure you get the best experience on our website. Learn more